BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Giordano G, Pancione M, Olivieri N, Parcesepe P, Velocci M, Di Raimo T, Coppola L, Toffoli G, D’Andrea MR. Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions. World J Gastroenterol 2017; 23(32): 5875-5886 [PMID: 28932079 DOI: 10.3748/wjg.v23.i32.5875]
URL: https://www.wjgnet.com/1007-9327/full/v23/i32/5875.htm
Number Citing Articles
1
Barbara Burgos-Blasco, Samuel Hernandez-Ruiz, Lorenzo Lopez-Guajardo, Juan Donate-Lopez. Dexamethasone intravitreal implant in cystoid macular edema secondary to paclitaxel therapyAmerican Journal of Ophthalmology Case Reports 2020; 18: 100653 doi: 10.1016/j.ajoc.2020.100653
2
Johannes Byrling, Agata Sasor, Johan Nilsson, Katarzyna Said Hilmersson, Roland Andersson, Bodil Andersson. Expression of peritumoral SPARC during distal cholangiocarcinoma progression and correlation with outcomeScandinavian Journal of Gastroenterology 2020; 55(6): 725 doi: 10.1080/00365521.2020.1774923
3
Mugahed Abdullah Hasan Albahde, Bulat Abdrakhimov, Guo-Qi Li, Xiaohu Zhou, Dongkai Zhou, Hao Xu, Huixiao Qian, Weilin Wang. The Role of Microtubules in Pancreatic Cancer: Therapeutic ProgressFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.640863
4
Rujing Chen, Leaf Huang, Kaili Hu. Natural products remodel cancer-associated fibroblasts in desmoplastic tumorsActa Pharmaceutica Sinica B 2020; 10(11): 2140 doi: 10.1016/j.apsb.2020.04.005
5
Tianqi Su, Bo Yang, Tianren Gao, Tongjun Liu, Jiannan Li. Polymer nanoparticle-assisted chemotherapy of pancreatic cancerTherapeutic Advances in Medical Oncology 2020; 12: 175883592091597 doi: 10.1177/1758835920915978
6
Iago Dillion Lima Cavalcanti, José Cleberson Santos Soares. Advances in Cancer Treatment2021; : 91 doi: 10.1007/978-3-030-68334-4_7
7
Pengcheng Zhang, He Tao, Liyang Yu, Lixiao Zhou, Chenggang Zhu. Developing protein arginine methyltransferase 1 (PRMT1) inhibitor TC-E-5003 as an antitumor drug using INEI drug delivery systemsDrug Delivery 2020; 27(1): 491 doi: 10.1080/10717544.2020.1745327
8
Weiwei Li, Gregory C. Wilson, Magdalena Bachmann, Jiang Wang, Andrea Mattarei, Cristina Paradisi, Michael J. Edwards, Ildiko Szabo, Erich Gulbins, Syed A. Ahmad, Sameer H. Patel. Inhibition of a Mitochondrial Potassium Channel in Combination with Gemcitabine and Abraxane Drastically Reduces Pancreatic Ductal Adenocarcinoma in an Immunocompetent Orthotopic Murine ModelCancers 2022; 14(11): 2618 doi: 10.3390/cancers14112618
9
Johannes Betge, Nadine Schulte, Sebastian Belle, Tianzuo Zhan, Beate Krammer-Steiner, Jean-Charles Moulin, Matthias Kleiß, Frank Lammert, Ulrich Wedding, Sebastian Räth, Martin Maenz, Lisa Hegele, Julian Larcher-Senn, Ralf Jesenofsky, Matthias P. Ebert, Nicolai Härtel. Neglected geriatric assessment and overtreatment of older patients with pancreatic cancer - Results from a prospective phase IV clinical trialJournal of Geriatric Oncology 2022; 13(5): 662 doi: 10.1016/j.jgo.2021.12.018
10
Naureen Ali, Nimisha Srivastava. Recent Advancements for the Management of Pancreatic Cancer: Current InsightsCurrent Cancer Therapy Reviews 2021; 17(4): 267 doi: 10.2174/1573394717666210625153256
11
Carsten Höltke, Martin Grewer, Miriam Stölting, Christiane Geyer, Moritz Wildgruber, Anne Helfen. Exploring the Influence of Different Albumin Binders on Molecular Imaging Probe DistributionMolecular Pharmaceutics 2021; 18(7): 2574 doi: 10.1021/acs.molpharmaceut.1c00064
12
Wanchun Zheng, Shouming Xu. <p>Analysis of Differential Expression Proteins of Paclitaxel-Treated Lung Adenocarcinoma Cell A549 Using Tandem Mass Tag-Based Quantitative Proteomics</p>OncoTargets and Therapy 2020; : 10297 doi: 10.2147/OTT.S259895
13
Matthew C Phillips, Shaker A Mousa. Clinical application of nano-targeting for enhancing chemotherapeutic efficacy and safety in cancer managementNanomedicine 2022; 17(6): 405 doi: 10.2217/nnm-2021-0361
14
Mahfoozur Rahman, Kainat Alam, Shipra Daniel, Afroze Alam, Sarwar Beg. Hormone Related Cancer Mechanistic and Nanomedicines2022; : 1 doi: 10.1007/978-981-19-5558-7_1
15
Rui Cao, Wenping Song, Cheng Ye, Xiujun Liu, Liang Li, Yi Li, Hongjuan Yao, Xiaofei Zhou, Liang Li, Rongguang Shao. Internal enhancement of DNA damage by a novel bispecific antibody-drug conjugate-like therapeutics via blockage of mTOR and PD-L1 signal pathways in pancreatic cancerCancer Medicine 2019; 8(2): 643 doi: 10.1002/cam4.1974
16
Julia Salapa, Allison Bushman, Kevin Lowe, Joseph Irudayaraj. Nano drug delivery systems in upper gastrointestinal cancer therapyNano Convergence 2020; 7(1) doi: 10.1186/s40580-020-00247-2
17
Sarah L. Skoczen, Kelsie S. Snapp, Rachael M. Crist, Darby Kozak, Xiaohui Jiang, Hao Liu, Stephan T. Stern. Distinguishing Pharmacokinetics of Marketed Nanomedicine Formulations Using a Stable Isotope Tracer AssayACS Pharmacology & Translational Science 2020; 3(3): 547 doi: 10.1021/acsptsci.0c00011
18
Xiangyu Fan, Haiyun Wu, Lisong Zhao, Xu Guo. A Poly-Chitosan and Cis-Platinum Conjugated Composite Nanoparticle System for Liver Cancer TherapyJournal of Biomedical Nanotechnology 2021; 17(9): 1726 doi: 10.1166/jbn.2021.3157
19
Tao Ma, Jin-Ling Jiang, Wei-Xiang Qi, Jia-Yi Chen, Hao-Ping Xu. A Novel Delivery System of RGD-HSA Loaded GEM/CUR Nanoparticles for the Treatment of Pancreatic Cancer TherapyDrug Design, Development and Therapy 2022; : 2395 doi: 10.2147/DDDT.S366558
20
Takashi Murakami, Yukihiko Hiroshima, Ryusei Matsuyama, Yuki Homma, Robert M. Hoffman, Itaru Endo. Role of the tumor microenvironment in pancreatic cancerAnnals of Gastroenterological Surgery 2019; 3(2): 130 doi: 10.1002/ags3.12225
21
Ishfaq Ahmed, Sam G. Pappas, Ashiq Masood. Animal Models in Cancer Drug Discovery2019; : 267 doi: 10.1016/B978-0-12-814704-7.00011-8
22
Sabrina Belbekhouche, Mélissande Cossutta, Damien Habert, Séna Hamadi, Tina Modjinou, Ilaria Cascone, José Courty. N6L-functionalized nanoparticles for targeted and inhibited pancreatic cancer cellsColloids and Surfaces A: Physicochemical and Engineering Aspects 2020; 607: 125461 doi: 10.1016/j.colsurfa.2020.125461
23
Cheng Qin, Gang Yang, Jinshou Yang, Bo Ren, Huanyu Wang, Guangyu Chen, Fangyu Zhao, Lei You, Weibin Wang, Yupei Zhao. Metabolism of pancreatic cancer: paving the way to better anticancer strategiesMolecular Cancer 2020; 19(1) doi: 10.1186/s12943-020-01169-7
24
Haonan Li, Runwei Jiao, Jiahui Mu, Shengtao Xu, Xu Li, Xianhua Wang, Zhanlin Li, Jinyi Xu, Huiming Hua, Dahong Li. Bioactive Natural Spirolactone-Type 6,7-seco-ent-Kaurane Diterpenoids and Synthetic DerivativesMolecules 2018; 23(11): 2914 doi: 10.3390/molecules23112914
25
Yan Shi, Quanli Han, Huan Yan, Yao Lv, Jing Yuan, Jie Li, Shasha Guan, Zhikuan Wang, Lei Huang, Guanghai Dai. S-1 Maintenance Therapy After First-Line Treatment With Nab-Paclitaxel Plus S-1 for Advanced Pancreatic Adenocarcinoma: A Real-World StudyFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.865404
26
Samantha J. Wade, Zeliha Sahin, Ann‐Katrin Piper, Sepehr Talebian, Morteza Aghmesheh, Javad Foroughi, Gordon G. Wallace, Simon E. Moulton, Kara L. Vine. Dual Delivery of Gemcitabine and Paclitaxel by Wet‐Spun Coaxial Fibers Induces Pancreatic Ductal Adenocarcinoma Cell Death, Reduces Tumor Volume, and Sensitizes Cells to RadiationAdvanced Healthcare Materials 2020; 9(21): 2001115 doi: 10.1002/adhm.202001115
27
Christian Chapa-González, Karina López, Kimberly Michelle Lomelí, Jorge Alberto Roacho-Pérez, Jazmín Cristina Stevens. A Review on the Efficacy and Safety of Nab-Paclitaxel with Gemcitabine in Combination with Other Therapeutic Agents as New Treatment Strategies in Pancreatic CancerLife 2022; 12(3): 327 doi: 10.3390/life12030327
28
Zhengliang Zhang, Xiangming Che, Ni Yang, Zhenghai Bai, Yuan Wu, Li Zhao, Honghong Pei. miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2Biomedicine & Pharmacotherapy 2017; 96: 1341 doi: 10.1016/j.biopha.2017.11.074
29
Vidhi M. Shah, Craig Dorrell, Adel Al-Fatease, Brittany L. Allen-Petersen, Yeonhee Woo, Yuliya Bortnyak, Rohi Gheewala, Brett C. Sheppard, Rosalie C. Sears, Adam WG. Alani. Microfluidics Formulated Liposomes of Hypoxia Activated Prodrug for Treatment of Pancreatic CancerPharmaceutics 2022; 14(4): 713 doi: 10.3390/pharmaceutics14040713
30
Diane Bressand, Anthony Novell, Alban Girault, William Raoul, Gaëlle Fromont-Hankard, Jean-Michel Escoffre, Thierry Lecomte, Ayache Bouakaz. Enhancing Nab-Paclitaxel Delivery Using Microbubble-Assisted Ultrasound in a Pancreatic Cancer ModelMolecular Pharmaceutics 2019; 16(9): 3814 doi: 10.1021/acs.molpharmaceut.9b00416
31
Cristina Martín-Sabroso, Ana Isabel Fraguas-Sánchez, Rafaela Raposo-González, Ana Isabel Torres-Suárez. Perspectives in Breast and Ovarian Cancer Chemotherapy by Nanomedicine Approach: Nanoformulations in Clinical ResearchCurrent Medicinal Chemistry 2021; 28(17): 3271 doi: 10.2174/0929867327666200819115403
32
Jianwen Zhou, Mingshuang Sun, Shanshan Jin, Li Fan, Wenquan Zhu, Xiaoyu Sui, Lixin Cao, Chunrong Yang, Cuiyan Han. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cellsDrug Delivery 2019; 26(1): 281 doi: 10.1080/10717544.2019.1580799
33
Jungwhoi Lee, Jungsul Lee, Woogwang Sim, Jae-Hoon Kim. Differential Dependency of Human Pancreatic Cancer Cells on Targeting PTEN via PLK 1 ExpressionCancers 2020; 12(2): 277 doi: 10.3390/cancers12020277
34
Paola Parente, Pietro Parcesepe, Claudia Covelli, Nunzio Olivieri, Andrea Remo, Massimo Pancione, Tiziana Pia Latiano, Paolo Graziano, Evaristo Maiello, Guido Giordano. Crosstalk between the Tumor Microenvironment and Immune System in Pancreatic Ductal Adenocarcinoma: Potential Targets for New Therapeutic ApproachesGastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/7530619
35
Mathilde Lorscheider, Alice Gaudin, Jessica Nakhlé, Kadi-Liis Veiman, Joël Richard, Christophe Chassaing. Challenges and opportunities in the delivery of cancer therapeutics: update on recent progressTherapeutic Delivery 2021; 12(1): 55 doi: 10.4155/tde-2020-0079
36
Xuan Zhang, Zhiming Zeng, Huiyi Liu, Li Xu, Xin Sun, Jing Xu, Guosheng Song. Recent development of a magneto-optical nanoplatform for multimodality imaging of pancreatic ductal adenocarcinomaNanoscale 2022; 14(9): 3306 doi: 10.1039/D1NR08394E
37
Haolin Song, Chen Jiang. Recent advances in targeted drug delivery for the treatment of pancreatic ductal adenocarcinomaExpert Opinion on Drug Delivery 2022; 19(3): 281 doi: 10.1080/17425247.2022.2045943
38
Kazuaki Taguchi, Yuko Okamoto, Kazuaki Matsumoto, Masaki Otagiri, Victor Chuang. When Albumin Meets Liposomes: A Feasible Drug Carrier for Biomedical ApplicationsPharmaceuticals 2021; 14(4): 296 doi: 10.3390/ph14040296
39
Abagail M. Delahoussaye, Joseph Abi Jaoude, Morgan Green, Tara N. Fujimoto, Jessica Molkentine, Carolina J. Garcia Garcia, Jason P. Gay, Ningping Feng, Joseph Marszalek, Natalie Fowlkes, Cullen M. Taniguchi. Feasibility of administering human pancreatic cancer chemotherapy in a spontaneous pancreatic cancer mouse modelBMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09255-3
40
Wanting Hou, Biao Yang, Hong Zhu. Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma ImmunotherapyPharmaceutics 2022; 14(10): 2033 doi: 10.3390/pharmaceutics14102033
41
Seung Soo Hong, Sena Lee, Sung Hwan Lee, Seonhowa Kim, Doyoung Kim, Hanseul Park, Jongook Lee, Jung Hwan Lee, Chang Moo Kang. Anticancer effect of locally applicable aptamer‐conjugated gemcitabine‐loaded atelocollagen patch in pancreatic cancer patient–derived xenograft modelsCancer Science 2022; 113(5): 1752 doi: 10.1111/cas.15318
42
Lukas M. Braun, Simon Lagies, Jessica Guenzle, Stefan Fichtner-Feigl, Uwe A. Wittel, Bernd Kammerer. Metabolic Adaptation during nab-Paclitaxel Resistance in Pancreatic Cancer Cell LinesCells 2020; 9(5): 1251 doi: 10.3390/cells9051251
43
Xin Luan, Hebao Yuan, Yudong Song, Hongxiang Hu, Bo Wen, Miao He, Huixia Zhang, Yan Li, Feng Li, Pan Shu, Joseph P. Burnett, Nathan Truchan, Maria Palmisano, Manjunath P. Pai, Simon Zhou, Wei Gao, Duxin Sun. Reappraisal of anticancer nanomedicine design criteria in three types of preclinical cancer models for better clinical translationBiomaterials 2021; 275: 120910 doi: 10.1016/j.biomaterials.2021.120910
44
Wangshu Dai, Xin Qiu, Changchang Lu, Zhengyun Zou, Huizi Sha, Weiwei Kong, Baorui Liu, Juan Du. AGIG Chemo-Immunotherapy in Patients With Advanced Pancreatic Cancer: A Single-Arm, Single-Center, Phase 2 StudyFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.693386
45
Si Shi, Chen Liang, Jin Xu, Qingcai Meng, Jie Hua, Xiujiang Yang, Quanxing Ni, Xianjun Yu. The Strain Ratio as Obtained by Endoscopic Ultrasonography Elastography Correlates With the Stroma Proportion and the Prognosis of Local Pancreatic CancerAnnals of Surgery 2020; 271(3): 559 doi: 10.1097/SLA.0000000000002998
46
Johannes Betge, Jing Chi-Kern, Nadine Schulte, Sebastian Belle, Tobias Gutting, Elke Burgermeister, Ralf Jesenofsky, Martin Maenz, Ulrich Wedding, Matthias P. Ebert, Nicolai Haertel. A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4665-2
47
Masahiro Yasunaga, Shino Manabe, Masaru Furuta, Koretsugu Ogata, Yoshikatsu Koga, Hiroki Takashima, Toshirou Nishida, Yasuhiro Matsumura. Mass spectrometry imaging for early discovery and development of cancer drugsAIMS Medical Science 2018; 5(2): 162 doi: 10.3934/medsci.2018.2.162
48
Yining Tao, Chenxu Yan, Dan Li, Jianfeng Dai, Yingsheng Cheng, Hui Li, Wei-Hong Zhu, Zhiqian Guo. Sequence-Activated Fluorescent Nanotheranostics for Real-Time Profiling Pancreatic CancerJACS Au 2022; 2(1): 246 doi: 10.1021/jacsau.1c00553
49
Ulrich M. Lauer, Can Yurttas, Julia Beil. Cancer Regional Therapy2020; : 17 doi: 10.1007/978-3-030-28891-4_2
50
Flore Pignon, Anthony Turpin, Olivia Hentic, Romain Coriat, Emma Salmon, Isabelle Baumgaertner, Nicolas Bertrand, Philippe Lévy, Vinciane Rebours, Pascal Hammel, Louis de Mestier. Efficacy and tolerance of gemcitabine and nab-paclitaxel in elderly patients with advanced pancreatic ductal adenocarcinomaPancreatology 2021; 21(6): 1064 doi: 10.1016/j.pan.2021.05.006
51
Shu Ming Chai, Ser Yee Lee. High Endothelial Venules and Pancreatic Ductal Adenocarcinoma: A potential game changerEBioMedicine 2019; 39: 29 doi: 10.1016/j.ebiom.2018.11.061
52
Duxin Sun, Simon Zhou, Wei Gao. What Went Wrong with Anticancer Nanomedicine Design and How to Make It RightACS Nano 2020; 14(10): 12281 doi: 10.1021/acsnano.9b09713
53
Dan Wang, Wenkai Feng, Xiaowei Wang, Dongfang Lin, Xuelei Wang, Xiaoru Guo, Qingfang Miao, Jie Ma, Guimin Xia. Promoted antitumor therapy on pancreatic cancer by a novel recombinant human albumin-bound miriplatin nanoparticleEuropean Journal of Pharmaceutical Sciences 2021; 167: 106000 doi: 10.1016/j.ejps.2021.106000
54
Anita Thyagarajan, Mamdouh Salman A. Alshehri, Kelly L.R. Miller, Catherine M. Sherwin, Jeffrey B. Travers, Ravi P. Sahu. Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic ApproachesCancers 2019; 11(11): 1627 doi: 10.3390/cancers11111627
55
Penelope Edwards, Byung Woog Kang, Ian Chau. Targeting the Stroma in the Management of Pancreatic CancerFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.691185
56
Wen-Quan Wang, Liang Liu, Jin-Zhi Xu, Xian-Jun Yu. Reflections on depletion of tumor stroma in pancreatic cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2019; 1871(2): 267 doi: 10.1016/j.bbcan.2019.01.007
57
Fei‐Ting Hsu, Chang Liang Tsai, I‐Tsang Chiang, Keng‐Hsueh Lan, Po‐Fu Yueh, Wen‐Yi Liang, Chi‐Shuo Lin, Yee Chao, Keng‐Li Lan. Synergistic effect of Abraxane that combines human IL15 fused with an albumin‐binding domain on murine models of pancreatic ductal adenocarcinomaJournal of Cellular and Molecular Medicine 2022; 26(7): 1955 doi: 10.1111/jcmm.17220